DRUG · Mapped RxNorm record
Sitagliptin
Normalized identity: sitagliptinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
NCT01590797
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Insulin
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
SitagliptinDRUG · verified · RxNorm: sitagliptin
PlaceboDRUG
InsulinBIOLOGICAL
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Merck Sharp & Dohme LLClead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01590797 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.